Trupanion, Inc. (NASDAQ:TRUP) Given Consensus Recommendation of "Hold" by Brokerages

Key Points

• Trupanion has a consensus “Hold” rating from six brokerages: five holds and one buy. The average 12-month price target is $39.20, although Piper Sandler recently downgraded the stock and cut its target to $32.
• The company’s latest quarterly results exceeded expectations, with earnings per share of $0.16 versus a $0.11 estimate and revenue of $392.93 million, up 11.1% year over year.
• Insiders sold 12,046 shares worth approximately $356,210 over the past three months, while several institutional investors—including Millennium Management and Invesco—expanded their positions.

Trupanion, Inc. (NASDAQ:TRUP - Get Free Report) has been given an average recommendation of "Hold" by the six brokerages that are currently covering the firm, Marketbeat Ratings reports. Five investment analysts have rated the stock with a hold rating and one has issued a buy rating on the company. The average 12 month target price among brokers that have issued ratings on the stock in the last year is $39.20.

A number of research analysts have recently commented on the stock. Piper Sandler downgraded shares of Trupanion from an "overweight" rating to a "neutral" rating and decreased their price objective for the company from $45.00 to $32.00 in a research report on Wednesday, August 26th. Stifel Nicolaus upped their target price on shares of Trupanion from $28.00 to $29.00 and gave the company a "hold" rating in a report on Thursday, August 20th. Weiss Ratings upgraded shares of Trupanion from a "hold (c-)" rating to a "hold (c)" rating in a research note on Wednesday, August 26th. Zacks Research cut Trupanion from a "strong-buy" rating to a "hold" rating in a report on Monday, August 24th. Finally, Atlantic Securities set a $42.00 price target on Trupanion in a report on Wednesday, July 15th.

Insider Activity

In related news, COO John Gallagher sold 3,604 shares of the business's stock in a transaction that occurred on Friday, August 28th. The stock was sold at an average price of $29.70, for a total transaction of $107,038.80. Following the transaction, the chief operating officer directly owned 33,742 shares of the company's stock, valued at approximately $1,002,137.40. The trade was a 9.65% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Margaret Tooth sold 978 shares of the stock in a transaction on Tuesday, August 11th. The shares were sold at an average price of $29.05, for a total value of $28,410.90. Following the completion of the sale, the chief executive officer owned 175,401 shares in the company, valued at approximately $5,095,399.05. This trade represents a 0.55% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 12,046 shares of company stock valued at $356,210 over the last three months. Insiders own 5.58% of the company's stock.

Hedge Funds Weigh In On Trupanion

Several large investors have recently modified their holdings of the stock. Royal Bank of Canada boosted its holdings in shares of Trupanion by 60.6% during the 1st quarter. Royal Bank of Canada now owns 29,763 shares of the financial services provider's stock worth $1,109,000 after buying an additional 11,233 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in Trupanion by 4.6% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 19,603 shares of the financial services provider's stock valued at $731,000 after buying an additional 858 shares during the last quarter. Millennium Management LLC raised its holdings in Trupanion by 73.5% in the 1st quarter. Millennium Management LLC now owns 267,976 shares of the financial services provider's stock valued at $9,987,000 after acquiring an additional 113,490 shares during the period. Invesco Ltd. raised its holdings in Trupanion by 35.1% in the 2nd quarter. Invesco Ltd. now owns 187,749 shares of the financial services provider's stock valued at $10,392,000 after acquiring an additional 48,781 shares during the period. Finally, Gabelli Funds LLC acquired a new stake in Trupanion during the second quarter worth approximately $249,000.

Trupanion Trading Up 1.9%

NASDAQ TRUP opened at $28.79 on Friday. The company has a market cap of $1.26 billion, a PE ratio of 54.32, a PEG ratio of 1.91 and a beta of 1.45. The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 0.24. Trupanion has a 12 month low of $21.16 and a 12 month high of $46.98. The stock has a 50 day moving average of $27.39 and a 200-day moving average of $25.87.

Trupanion (NASDAQ:TRUP - Get Free Report) last issued its earnings results on Wednesday, August 5th. The financial services provider reported $0.16 earnings per share for the quarter, topping analysts' consensus estimates of $0.11 by $0.05. Trupanion had a net margin of 1.53% and a return on equity of 5.96%. The business had revenue of $392.93 million for the quarter, compared to the consensus estimate of $389.72 million. During the same period in the previous year, the company earned $0.22 earnings per share. The firm's revenue for the quarter was up 11.1% on a year-over-year basis. On average, equities research analysts anticipate that Trupanion will post 0.63 EPS for the current fiscal year.

About Trupanion

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company's core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source